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ABSTRACT
Objectives: Describe dietary intake of participants
enrolled in a non-prescriptive dietary intervention and
dietary changes at 6 months and explore whether these
changes had a role in observed improvements in glycated
haemoglobin (HbA1c), weight, lipids and blood pressure.
Design: Secondary analysis of data from the Early ACTivity
in Diabetes randomised controlled trial.
Participants: 262 patients with newly diagnosed type 2
diabetes randomised to the dietary intervention.
Outcomes and analysis: Changes in energy intake,
macronutrients, fibre and alcohol and in weight, waist
circumference, lipids, HbA1c and blood pressure at
baseline and 6 months. Multivariate models were used to
examine associations between dietary changes and
metabolic variables.
Results:Men reported reducing mean energy intake from
1903±462 kcal to 1685 kcal±439 kcal (p<0.001),
increasing carbohydrate intake from 42.4±6.6% to 43.8
±6.6% (p=0.002) and reducing median alcohol intake from
13 (0–27) g to 5 (0–18) g (p<0.001). Women reported
reducing mean energy intake from 1582±379 kcal to 1459
±326 kcal (p<0.001) with no change to macronutrient
distribution and alcohol. Fibre intake was maintained. In
men (n=148), weak and clinically insignificant associations
were found between increased carbohydrates and
reduction in HbA1c (β=−0.003 (−0.006, −0.001);
p=0.009), increased fibre and reduction in total cholesterol
(β=−0.023 (−0.044, −0.002); p=0.033), decreased total fat
and reduction in low-density lipoprotein (LDL)-cholesterol
(β=0.024 (0.006, 0.001); p=0.011), and decreased alcohol
and reduction in diastolic blood pressure (β=0.276 (0.055,
0.497); p=0.015). In women (n=75), associations were
found between a decrease in transfats and reductions in
waist circumference (β=−0.029 (0.006, 0.052); p=0.015),
total cholesterol (β=0.399 (0.028, 0.770); p=0.036) and
LDL cholesterol (β=0.365 (0.042, 0.668); p=0.028).
Conclusions: Clinically important metabolic
improvements observed in a patient-centred dietary
intervention were not explained by changes in
macronutrients. However, a non-prescriptive approach may
promote a reduction in total energy intake while
maintaining fibre consumption.
Trial registration number: The Early ACTID trial number
ISRCTN92162869.
INTRODUCTION
Dietary management is recognised as highly
important in the treatment of type 2 diabetes
mellitus (type 2 DM). Based on meta-analyses
of exercise and diet studies, the American
Diabetes Association (ADA) and European
Association for the Study of Diabetes (EASD)
recommend that lifestyle interventions should
be initiated as the first step in treating new-
onset type 2 DM.1 Over the past 3 years, The
Look Ahead research group, the Lifestyle Over
and Above Drugs in Diabetes (LOADD) and
Early ACTivity in Diabetes (Early ACTID) ran-
domised controlled trials (RCTs) have shown
that dietary interventions which target weight
reduction are beneficial and improve glycaemic
control.2–4 These trials achieved reductions in
glycated haemoglobin (HbA1c) comparable to
Strengths and limitations of this study
▪ Describes the dietary intake of people soon after
diagnosis of type 2 diabetes mellitus and living
in the UK, the dietary changes made during a
dietary intervention and explores associations
between dietary changes and changes in meta-
bolic outcomes. This intervention was based on
the dietary advice that is given in routine clinical
practice in the UK.
▪ The sample was predominantly white but was
socioeconomically diverse and 40% of partici-
pants lived in areas of high economic
deprivation.
▪ Only 53% of the participants provided the food
diary data at the end of the trial, and these
people showed greater improvements in meta-
bolic outcomes than those who did not return
the food diaries. It is probable that they were
more motivated than a typical patient group and
this limits the generalisability of the findings.
▪ The use of self-reported dietary measures is a
limitation in dietary studies due to the potential
for under-reporting food intake.
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reductions demonstrated in patients starting metformin or
a gliptin as monotherapies,5 and although the Look Ahead
trial showed no reduction in cardiovascular events after
9.6 years, participants in the intervention arm were less
likely to be treated with insulin.6
It has been reported that changes to the macronutrient
composition of the diet may impact on glycaemic
control, blood lipids and weight,7 but the effects of spe-
cific dietary changes on these metabolic outcomes are
still unclear and no single ‘diet for diabetes’ has been
identified.8 In recognition of this, the 2012 ADA and
EASD joint guidelines and 2011 Diabetes UK nutritional
guidelines emphasise the importance of an individua-
lised, patient-centred approach to diet rather than a pre-
scriptive approach.1 9 This approach recognises that
different people have individual dietary habits and may
find certain dietary changes more straightforward than
others. There is evidence that men and women living in
the UK have differing dietary patterns.10 Men have been
reported to drink more alcohol and consume more meat
but less fruit and diet soft drinks than women11 Few
studies have looked at what changes are made to macro-
nutrients in response to non-prescriptive dietary advice,
whether men and women make different changes and
whether these changes impact on metabolic control.
The Early ACTID trial included a non-prescriptive,
patient-centred dietary intervention. The trial aimed to
assess whether adding physical activity to a dietary inter-
vention produced greater benefit than diet alone or
usual care in individuals newly diagnosed with type 2
DM.4 Participants who received the lifestyle interven-
tions had better HbA1c, lower body weight, less insulin
resistance and were on less medication than the control
group at 6 and 12 months. During the intervention, par-
ticipants in this cohort reported small changes to higher
calorie, low-fibre foods. Examination of the specific
changes to foods and food groups reported by partici-
pants has been previously published12 and this current
paper focuses on macronutrients.
The aim of this paper is to describe baseline energy
and macronutrient intakes of men and women who were
enrolled into the dietary intervention in the Early
ACTID study and to examine reported dietary changes
made after 6 months.
We conducted exploratory analysis to examine the fol-
lowing hypotheses:
▸ Men and women with type 2 DM make different
dietary changes in response to a dietary intervention.
▸ The changes to energy intake and macronutrients are
associated with beneficial changes to glycaemic
control, weight, waist circumference, blood pressure
and lipids.
METHODS
Participants
This paper is an exploratory analysis of data from the
Early ACTID RCT. Early ACTID was a diet and physical
activity trial involving patients living in the south west of
England who were recruited within 5–8 months of a diag-
nosis of type 2 DM from December 2005 to September
2008. Full trial procedures with the CONSORT diagram
and results are described elsewhere.4 13 14 The analysis is
limited to participants in the intervention arms who
returned valid food diary data.
Overview of the dietary intervention
Patients in the diet alone and the diet and physical activ-
ity groups received the same dietary intervention. For
the first 6 months, the intervention aimed to promote
dietary change. At randomisation, patients attended a
1 h appointment with a study dietitian followed by two
further visits of 30 min. These visits were supported by
six additional visits to a research nurse, where 15 min
were used to discuss dietary matters for both groups,
reinforcing dietary goals and 15 min to discuss either
physical activity or other matters pertinent to the
patient, depending on the intervention group to which
they were allocated. Maintenance was the primary goal
of the second 6 months and consisted of two more
30 min dietitian visits and four additional visits to the
research nurses.
The dietary intervention was based on the 2003
Diabetes UK healthy eating guidelines15 and employed
goal–oriented, motivational interviewing16 Patients were
encouraged to discuss their reasons for change,
any ambivalence about change and to set their own
dietary goals and identify their own strategies for achiev-
ing these goals. Prescriptive daily requirements for
energy or macronutrients were not calculated unless
requested by the patient and prescriptive meal plans or
food lists were not used. Instead, patients received study
specific, written dietary information at each visit (avail-
able at: http://jcrubristol.org.uk/EA/ACTID%20patients
%20Handbook/Forms/AllItems.aspx) and were encour-
aged to use this to evaluate their own eating habits. The
materials included information on maintaining a regular
meal pattern and including starchy carbohydrates as a
part of each meal, reducing total, saturated and trans fat
intake, limiting non-milk extrinsic sugars, aiming for five
portions a day of fruit and vegetables and gave guidance
on portion control. Specific food choices were discussed
and participants were advised on choosing wholegrain
and higher fibre foods, reducing fatty and processed
meats and high fat dairy products and increasing oily fish
and limiting foods such as cakes, biscuits, salty snacks
and takeaway meals. The benefit of aiming for a 5–10%
weight loss by reducing overall energy intake was dis-
cussed with everyone. Goals were reviewed at each
appointment and successes, difficulties and new strat-
egies discussed. Patients were encouraged to self-monitor
their weight and diet.
Measurements
Measures were taken at baseline (prior to randomisa-
tion) and repeated 6 and 12 months later. Baseline and
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6-month data were used in the current analysis, since
outcomes at 6 months were defined as the primary end-
point of the study. Measurements used in this analysis
were weight, height (to calculate body mass index
(BMI)), waist circumference, blood pressure, HbA1c,
fasting lipids and minutes of moderate-to-vigorous phys-
ical activity (MVPA) measured using accelerometry and
defined as activity expending greater than 3 kcal/kg/h.
As previously described, blood measurements and
anthropometric measures were carried out using stan-
dardised procedures.13 Smoking habits and use of
dietary supplements were assessed by a research nurse.
The UK Index of Multiple Deprivation (IMD) 2007 was
calculated from the home postcode and used as an indi-
cator of socioeconomic position.17
Dietary assessment and analysis
Patients in the intervention arms were asked to complete
4-day food diaries, to include two weekdays and one
weekend day, prior to each appointment with a dietitian,
recording all foods and drinks consumed during those
4 days. Portion sizes were estimated using household
measures and package weights and brands indicated
where appropriate. The diaries were discussed during
the appointments and used to identify potential areas
for change and difficulties in making change, and to
enable patients to observe change in their diets over
time. Patients were asked to return all the diaries at the
final visit for further analysis. Those who did not return
the diaries at the visit were reminded by telephone and
email to post the outstanding diaries to the research
team after the visit.
Baseline and 6-month food diaries were coded by one
coder and checked for accuracy and agreement by a
second coder, using the dietary coding programme Diet
in Data Out (DIDO), developed at the Medical Research
Council Human Nutrition Unit in Cambridge, UK.18
Diaries were analysed with the nutrient analysis pro-
gramme Bristol General Analysis of Dietary Experiments
(BRIGADE).19 The nutrient database is based on
McCance and Widdowson’s Composition of Foods, 5th edition,20
updated with the supplements to that edition, new data
from the 6th edition and manufacturers’ data. Additional
nutrient data from the INTERMAP nutrient database for
the UK were also used.21 If no portion size information
was given, age-appropriate portion sizes were assigned.22
The mean daily consumption of each nutrient was calcu-
lated for each participant.
Statistical analysis
As the dietary intervention was designed to be identical
for both intervention groups and there were no differ-
ence in outcomes between the diet and diet and phys-
ical activity groups, the data were analysed as a cohort.
Patients in the usual care group were excluded from the
analysis since they did not receive the dietary interven-
tion and were not asked to complete a diary at
6 months. Descriptive statistics were used for patient
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characteristics and for intakes of macronutrients at base-
line and at 6 months. Variables were checked for normal
distribution; non-normal variables were log transformed
prior to analysis. For ease of interpretation, arithmetic
means and back transformed variables are presented.
Independent t tests were used to explore differences in
continuous variables between men and women at base-
line and between those who did and did not return food
diaries, and χ2 tests were used to explore differences in
dichotomous variables. Paired sample t tests were used
to describe differences in energy and macronutrient
intake between baseline and 6 months. McNemar tests
were used to explore differences in numbers of people
meeting recommendations at baseline and at 6 months.
As alcohol variables could not be transformed, the
Mann Whitney U and paired sample Wilcoxon signed
rank test were used to describe differences. Cases with
missing data were excluded listwise. Data were assumed
to be randomly missing and table 1 includes numerical
superscripts to indicate the number of participants with
missing data for the variable of interest.
Multivariate regression models were used to conduct
exploratory analysis to investigate associations between
changes in energy and macronutrient intake and the
metabolic variables at 6 months in those who provided
valid physical activity data. Changes in energy intake
were explored using a standard multivariate model.
Each macronutrient was explored independently using a
multivariate nutrient density model to adjust for change
in energy intake. Change in percentage energy from
each macronutrient was calculated and entered into the
model with change in total energy included as a covari-
ate. Change in fibre intake was explored using a stand-
ard multivariate model and entered as an absolute
intake (in Grams) with change to total energy intake as
a covariate.23 Models were adjusted for age, BMI, time
since diagnosis, minutes of MVPA and dichotomous yes/
no variables for smoking status, relevant lipid lowering,
blood pressure and diabetes medication and dietary sup-
plement use at 6 months.
Owing to the number of different analyses that were
conducted, the results are interpreted in terms of
strength of evidence of associations.24 This is an explora-
tory analysis and as such has not been adjusted for mul-
tiple comparisons;25 26 consequently, p values of <0.05
are interpreted as some evidence of association, p<0.01
as increasing evidence and p<0.001 as strong evidence.
RESULTS
Study participants
A total of 593 patients were recruited into the Early
ACTID study, with 494 being assigned to one of the
intervention groups. In total, 396 (80%) patients were
recorded as completing food diaries both at baseline
and at 6 months, but only 262 (53%) patients returned
them. Metabolic and dietary outcomes at baseline and at
6 months are presented for these 262 patients. At
6 months, 491 (99%) patients assigned to one of the
intervention arms remained in the study, with 434
(88%) attending all scheduled visits up to that point
and a further 37 (8%) attending all except one.
Mean age was 62.4 (9) years, 97% of patients were
white, 83% were married or with a long-term partner
and 41% were in the lowest IMD quartile. At baseline,
104 (40%) participants were on oral hypoglycaemic
medication, 170 (65%) on lipid lowering medication
and 174 (66%) on blood pressure medication. Only 6%
of patients were current smokers at baseline. Men and
women had similar characteristics, although there was
some evidence that men were more likely to be on lipid
lowering medication than women (69% vs 56%,
p=0.041). At 6 months, 105 (40%) participants were on
oral hypoglycaemic medication, although 12 (5%) parti-
cipants had increased the dose and 4 (2%) had
decreased it; 177 (68%) were on lipid lowering medica-
tion and 175 (67%) were on blood pressure medication.
Compared with patients who did not return food
diaries, those who did were older (62 vs 57 years,
p<0.001), with a lower mean weight (88.2 vs 93.3 kg,
p=0.001), lower mean BMI (30.7 vs 32.5, p=0.001) and
lower mean waist circumference (105 vs 108 cm,
p=0.025), but there was no difference in glycaemic
control, lipids and blood pressure.
Metabolic outcomes
Table 1 shows the metabolic outcomes at baseline and at
6 months for those who returned food diaries. There
was no difference in glycaemic control or blood pressure
between men and women, but women had higher total
(p<0001) low-density lipoprotein (LDL; p<0.001) and
high-density lipoprotein (HDL; p=0.015) cholesterol
levels.
Weight, waist circumference and BMI improved at
6 months for men and women (p<0.001). Men and
women improved their HbA1c (men: p=0.006; women:
p<0.001). Men improved their fasting blood glucose
(p=0.006) and there is some evidence that women
increased their HDL cholesterol (p=0.033).
At 6 months, those who returned food diaries had lost
more weight (2.4 vs 1.3 kg, p=0.001), reduced waist cir-
cumference more (2.7 vs 1.3 cm, p=0.022) and reduced
HbA1c (0.18% (2 mmol/L) vs 0% (0 mmol/L), p=0.02).
Nutrient analysis
Table 2 shows the mean reported energy and nutrient
intakes at baseline and at 6 months and their mean
reported changes.
At baseline, participants reported generally good
dietary habits. 61% of women and 59% of men reported
the recommended total fat intake (less than 35% of
energy from total fat) and 55% of women and 66% of
men reported a low-to-moderate carbohydrate intake
(<45% of energy). Men were more likely to drink alcohol
and more likely to drink to excess than women, with 49%
of women and 28% of men recording no alcohol during
4 England CY, Thompson JL, Jago R, et al. BMJ Open 2014;4:e004953. doi:10.1136/bmjopen-2014-004953
Open Access
Table 2 Nutrient intake at baseline and at 6 months
Mean daily intake
nutrients
Baseline 6 months Change (6 months−baseline)
Total
(n=262)
Women
(n=87) Men (n=175)
Total
(n=262)
Women
(n=87) Men (n=175)
Total
(n=262)
Women
(n=87) Men (n=175)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Energy (kcal) 1796 (461) 1582 (379) 1903 (462)c 1610 (418) 1459 (326) 1685 (439)c −187 (315)z −123 (270)z −218 (332)a z
Protein (g) 80 (19) 73 (16) 83 (20)c 74 (19) 68 (13) 77 (20)c −6 (17)z −5 (15)y −6 (19)z
Total carbohydrates (g) 202 (55) 186 (48) 211 (57)b 186 (53) 170 (39) 194 (58)b −17 (41)z −15 (33)z −17 (45)z
Total sugar (g) 81 (32) 77 (28) 83 (34) 75 (31) 71 (23) 77 (34) −6 (26)z −6 (21)x −6 (28)y
Starch (g) 119 (36) 105 (30) 126 (37)c 109 (31) 97 (26) 115 (32)c −10 (28)z −9 (24)y −11 (30)z
Non-starch
polysaccharide (g)
17 (5) 16 (5) 17 (5) 16 (5) 15 (4) 17 (5)a −1 (5) −1 (4) 0 (5)
Total fat (g) 69 (22) 61 (20) 73 (220)c 61 (20) 56 (19) 64 (20)b −8 (18)z −5 (17)x −9 (18)z
Saturated fat (g) 23 (9) 21 (8) 24 (9)b 20 (9) 19 (9) 21 (9) −3 (8)z −2 (7)x −3 (8)z
Trans fat (g) 2.3 (1.1) 2.0 (1) 2.4 (1.1)b 2.1 (1.1) 1.9 (1.1) 2.2 (1.1)a −0.2 (1.1)y −0.1 (1.1) −0.3 (1.2)y
Monounsaturated fat (g) 24 (8) 21 (8) 26 (8)c 22 (8) 20 (7) 23 (8)b −2 (7)z −1 (8)x −3 (7)z
Polyunsaturated fat (g) 13 (6) 12 (6) 14 (6)a 12 (4) 11 (4) 13 (5)a −1 (5)z −1 (6) −1 (5)y
Alcohol, median (IQR) (g) 7 (0–23) 1 (0–12) 13 (0–27)a 4 (0–16) 0 (0–11) 5 (0–18)b 0 (−3−1)z 0 (−3−4) −3 (−14−0)c z
% Energy from protein 18.3 (3.6) 19.0 (3.7) 18.0 (3.5)a 18.8 (3.5) 19.0 (3.3) 18.7 (3.6) 0.5 (3.7)z 0.0 (3.6) 0.7 (3.8)y
% Energy from total
carbohydrates
43.2 (6.6) 44.8 (6.4) 42.4 (6.6)a 44.1 (6.5) 44.7 (6.2) 43.8 (6.6) 0.9 (6.0)z −0.1 (6.2) 1.4 (5.9)y
% Energy from total fat 33.5 (5.6) 33.4 (5.8) 33.6 (5.5) 33.3 (5.8) 33.3 (6.4) 33.3 (5.4) −0.2 (5.9) −0.1 (6.3) −0.3 (5.7)
% Energy from
saturated fat
11.2 (3.1) 11.4 (3.4) 11.2 (3.1) 11.0 (3.4) 11.1 (3.6) 10.9 (3.2) −0.3 (3.3) −0.3 (3.1) −0.3 (3.5)
% Energy from trans fat 1.1 (0.4) 1.1 (0.43) 1.1 (0.5) 1.1 (0.5) 1.1 (0.4) 1.1 (0.5) 0.0 (0.5) 0.0 (0.5) 0.0 (0.5)
% Energy from
monounsaturated fat
11.7 (2.5) 11.5 (2.6) 11.9 (2.5) 11.9 (2.5) 11.7 (2.7) 12.0 (2.5) −0.2 (2.8) 0.2 (3.2) 0.1 (2.6)
% Energy from
polyunsaturated fat
6.5 (2.2) 6.7 (2.4) 6.4 (2.1) 6.6 (1.9) 6.6 (1.9) 6.6 (1.9) 0.1 (2.4) 0.0 (2.6) 0.2 (2.3)
% Energy from total sugar 17.2 (5.7) 18.7 (5.5) 16.5 (5.6)b 17.7 (5.7) 18.8 (5.4) 17.2 (5.8)a 0.5 (5.0) 0.2 (5.2) 0.7 (4.9)
% Energy from alcohol 3 (0–8) 1 (0–5) 5 (0–9)c 2 (0–7) 0 (0–6) 2 (0–7)a 0 (−3−1)z 0 (−1−2) −1 (−4−0)c z
a=p<0.05; b=p<0.005; c=p<0.001 women vs men.
y=p<0.005; z=p<0.001 baseline vs 6 months.
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the 4 days and 8% of women and 19% of men reporting
more than 30 g of alcohol per day (p=0.022).
At 6 months, the mean daily reported energy intake
was reduced by 187 kcal (p<0.001). Men reduced their
energy intake more than women (218±332 vs 123
±270 kcal/day, p=0.022). This was achieved by small
reductions in all macronutrients, while maintaining fibre
intake. The mean percentage energy from macronutri-
ents was unchanged for women while men reported a
small mean increase of 1.4±5.9% (p<0.001) of energy
from carbohydrates. Men reported reducing their
median alcohol intake (p<0.001), with 40% reporting
no alcohol during the 4 days and 15% reporting more
than 30 g/day. There was no reported median change in
alcohol intake for women. Despite no mean change to
energy from saturated fat, more men met recommenda-
tions at 6 months (35% men at baseline vs 49% at
6 months reporting less than 10% energy from saturated
fat, p=0.007). There was no change in the number of
women meeting recommendations (40% baseline vs
44% at 6 months, p=0.71).
Valid physical activity data and dietary data were pro-
vided by 223 (45%) participants. Table 3 shows the
regression coefficients and CIs for changes in energy
and macronutrients that show evidence of associations
with specific metabolic variables. In men, a 1% reduc-
tion in energy from alcohol was associated with a
0.276 mm Hg reduction in diastolic blood pressure
(95% CI 0.055 to 0.497). In women, a 1% reduction in
energy from trans fat was associated with a decrease in
cholesterol of 0.399 mmol/L (95% CI 0.028 to 0.770).
In men, a 1% increase in energy from carbohydrate was
associated with a decrease in HbA1c of 0.003% (95% CI
−0.006 to −0.001). There were no associations between
change in energy intake and the metabolic variables.
DISCUSSION
Main findings
The main findings from this exploratory analysis are that
patients who were randomised to the intervention arms
in the Early ACTID study and returned food diaries
reported a good diet at baseline but still achieved small
dietary changes. They reported a mean decrease in
energy intake of around 200 kcal/day during the first
6 months. This is a modest reduction in calorie intake,
but if sustained will have an impact on weight and gly-
caemic control. It has been argued that small changes in
the long term are more effective for weight management
than large changes in the short term.27 Men reported a
reduced alcohol intake that produced a greater reduc-
tion in energy and reported a small increase in the per-
centage energy from carbohydrate. Women reported
modest reductions to all macronutrients but made no
changes to alcohol, their energy reduction was less and
the macronutrient ratio of their diets did not change.
Both sexes maintained fibre intake. Although changes in
percentage intake of macronutrients were associated with
metabolic outcomes, these effect sizes were too small to
be of clinical significance.
Comparison with other studies
The Early ACTID dietary intervention was a pragmatic,
‘real world’ intervention, in which participants discussed
dietary advice with dietitians and nurses to decide on
their own dietary changes. The approach contrasts with
dietary studies where participants are asked to make spe-
cific, prescribed changes to the macronutrient compos-
ition, by lowering carbohydrate and increasing
protein,28–30 or to lower the glycaemic index.31 32 The
LOADD trial3 based a successful dietary intervention in
patients with poor glycaemic control on very similar
recommendations to those used in the Early ACTID
intervention, but total energy intake and macronutrient
ratios for each participant were calculated and diets
were prescribed according to these calculations taking
into account personal preference, budget and sociocul-
tural factors. The Early ACTID intervention did not
compare a prescriptive with a non-prescriptive approach,
so it cannot be used to demonstrate that this is superior,
but reductions in weight, waist circumference and
HbA1c were achieved that are comparable to those
achieved during these interventions. Withdrawal rates
for prescriptive dietary interventions range from 10% to
30% and these higher withdrawal rates may suggest that
in routine clinical care a more flexible approach can be
advantageous in promoting retention. Of those partici-
pants in Early ACTID who either did not attend all
appointments or withdrew completely, only one person
stated that they did not see the benefit of the trial. The
majority could not schedule all nine dietitian and nurse
visits because of other commitments, five cited other
health issues, three moved too far away, one said they
‘did not want to diet,’ one wanted to take orlistat from
baseline and three gave no reasons. What is common to
intervention trials in diabetes is that patients receive
individual support and attend multiple appointments
with a dietitian or a health practitioner who is an expert
in promoting dietary change. It is important to empha-
sise that this model is not routinely replicated in primary
care for patients with type 2 DM.
Exploratory analysis of the associations between spe-
cific dietary changes and metabolic outcomes found
small effect sizes that are not clinically important, but
they are consistent with existing nutritional data on the
benefits of a reduction in trans fats on lipids and waist
circumference,33 an increase in fibre on LDL choles-
terol34 and a reduction in alcohol and blood pressure.35
It is of interest that this analysis found that there was no
benefit in carbohydrate reduction in men with good gly-
caemic control who are already consuming a
low-to-moderate carbohydrate diet. It is not possible to
determine whether there is an optimum macronutrient
distribution for T2 DM from this analysis, particularly in
those with poor glycaemic control, but there is no
unequivocal evidence that low-carbohydrate diets
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produce better blood glucose control or weight loss
than higher carbohydrate diets.36 A meta-analysis of low-
carbohydrate diets versus low-fat diets conducted in
201237 concluded that there was evidence of a small but
beneficial effect on lipid profiles of a low (defined as
<45% energy from carbohydrate) or very low carbohy-
drate (<60 g carbohydrate) diet but no difference in
improvements to weight or glycaemic control. Larsen
et al29 correlated dietary change with metabolic out-
comes and found associations with energy reduction
and HbA1c and waist circumference.
Strengths and weaknesses
To the best of our knowledge, this is the first study to
describe the dietary intake of people soon after diagno-
sis with type 2 DM living in the UK, the dietary changes
made during an intervention based on patient-centred,
non-prescriptive dietary advice and that examines asso-
ciations between dietary change and metabolic variables.
The demographics of the Early ACTID participants
included in this analysis suggest that these findings are
only representative of the white population; however, the
sample is socioeconomically diverse with 40% of the par-
ticipants living in areas of high economic deprivation.
Ethical approval was granted to make no changes to
hypoglycaemic, lipid lowering or blood pressure medica-
tions during the first 6 months, unless absolutely neces-
sary, and this was controlled by a strict protocol. Owing
to the small numbers, those participants who made
medication changes were included in the analysis
without correction.
The study has important weaknesses. Only 53% of
the participants returned the baseline and 6 month
food diaries at the end of the trial, and these people
had a lower BMI and waist circumference at baseline
and achieved greater metabolic improvements. The par-
ticipants who did not return the diaries reported mis-
laying them, which may indicate less motivation and
less engagement with the trial. Participants who did
return the diaries could have been more motivated to
make dietary changes than a typical patient population,
and given that their diets were good at baseline, may
already have made dietary changes prior to entry into
the Early ACTID study. The relative lack of dietary data
limits our ability to generalise these findings to broader
patient groups. Furthermore, this was an exploratory
analysis using an existing dataset and as such an estima-
tion of sample size was not conducted in advance.
However, post hoc sample calculations indicate that the
study was underpowered to detect small associations
between dietary changes and metabolic outcomes,
having 15% power for women and 52% for men at an
α of 0.05.
The use of any self-reported measure of diet, includ-
ing 4-day food diaries, is a recognised limitation in
dietary studies. Under-reporting of food intake and
selective under-reporting or under-eating of foods per-
ceived to be ‘bad’ are commonly documented, especially
in people who are obese.38 39 Measurement of alcohol
can be problematic due to the episodic nature of con-
sumption, although including at least one weekend day
can improve estimates by including alcohol consumption
of ‘weekend-only’ drinkers.40 Methods exist to estimate
under-reporting, using the calculated basal metabolic
rate and estimates of physical activity,41 42 but these
methods assume that an individual’s weight is stable and
are consequently inappropriate for use during a weight
loss trial. It should be noted that other dietary interven-
tions in patients with type 2 DM have reported similar
energy intakes28 31 and an energy reduction of around
Table 3 Associations between macronutrients and metabolic outcomes in men (n=148) and women (n=75) who provided
physical activity data
Macronutrient Metabolic outcomes
Regression coefficient,
β (95% CI) p value
Change to % energy from total carbohydrates Men HbA1c % (mmol/L) −0.003 (−0.006 to −0.001)
(−0.005 (−0.009 to −0.001))
0.009
Change to fibre (NSP) intake (g) All Total cholesterol −0.023 (−0.044 to −0.002) 0.033
Men Total cholesterol −0.025 (−0.047 to −0.003) 0.023
Change to % energy from total fat All LDL cholesterol 0.018 (0.003 to 0.032) 0.016
Men LDL cholesterol 0.024 (0.006 to 0.042) 0.011
Change to % energy from trans fat All Waist circumference 0.014 (0.003 to 0.024) 0.011
Women Waist circumference 0.029 (0.006 to 0.052) 0.015
Total cholesterol 0.399 (0.028 to 0.770) 0.036
LDL cholesterol 0.365 (0.042 to 0.688) 0.028
Change to % energy from monounsaturated fats All LDL cholesterol 0.036 (0.006 to 0.065) 0.018
Change to % energy from alcohol All Diastolic blood pressure 0.217 (0.020 to 0.414) 0.031
Men Diastolic blood pressure 0.276 (0.055 to 0.497) 0.015
All models are adjusted for change in energy intake, outcome at baseline, age, BMI, time since diagnosis, relevant hypoglycaemic mediation
(metformin, sulfonylureas, glitazones), lipid lowering medication or antihypertensives, dietary supplements, mean daily minutes of
moderate-to-vigorous physical activity.
For each macronutrient listed, a 1% (1 g for fibre) increase is associated with the change in outcome listed.
BMI, body mass index; HbA1c, glycated haemoglobin; LDL, low-density lipoprotein; NSP, non-starch polysaccharide.
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200 kcal/day is plausible assuming a dynamic model of
energy balance43 and given the modest weight reduction
observed. It is also important to note that this is a sec-
ondary analysis, so cause and effect cannot be assumed.
It was not possible to perform a formal mediation ana-
lysis since participants from the control arm were not
asked to complete a food diary at 6 months.
CONCLUSION
The Early ACTID trial indicates that a flexible, non-
prescriptive approach to dietary advice based on stand-
ard healthy eating guidelines in type 2 DM given soon
after diagnosis may be effective in promoting small
dietary change, even in patients with good glycaemic
control. This supports current clinical practice and
guidelines. The current analysis suggests that changes in
percentage intake of macronutrients do not have any
clinically significant effect on metabolic outcomes.
However, this needs confirmation in a larger cohort,
with less good glycaemic control. Further research is
needed on whether dietary changes made using a non-
prescriptive approach are sustainable and beneficial in
the longer term in a more typical patient population.
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